Literature DB >> 8282706

Vancomycin-resistant Leuconostoc mesenteroides and Lactobacillus casei synthesize cytoplasmic peptidoglycan precursors that terminate in lactate.

S Handwerger1, M J Pucci, K J Volk, J Liu, M S Lee.   

Abstract

The emergence of acquired high-level resistance among Enterococcus species has renewed interest in mechanisms of resistance to glycopeptide antibiotics in gram-positive bacteria. In Enterococcus faecalis and Enterococcus faecium, resistance is encoded by the van gene cluster and is due to the production of a peptidoglycan precursor terminating in D-alanyl-D-lactate, to which vancomycin does not bind. Most Leuconostoc and many Lactobacillus species are intrinsically resistant to high levels of glycopeptide antibiotics, but the mechanism of resistance has not been elucidated. To determine whether the mechanisms of resistance are similar in intrinsically resistant bacteria, cytoplasmic peptidoglycan precursors were isolated from Leuconostoc mesenteroides and Lactobacillus casei and analyzed by mass spectrometry, revealing structures consistent with UDP-N-acetylmuramyl-L-Ala-D-Glu-L-Lys-(L-Ala)-D-Ala-D-lactate and UDP-N-acetylmuramyl-L-Ala-D-Glu-L-Lys-D-Ala-D-lactate, respectively.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8282706      PMCID: PMC205040          DOI: 10.1128/jb.176.1.260-264.1994

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  19 in total

1.  Biosynthesis of the peptidoglycan of bacterial cell walls. XVII. Biosynthesis of peptidoglycan and of interpeptide bridges in Lactobacillus viridescens.

Authors:  R Plapp; J L Strominger
Journal:  J Biol Chem       Date:  1970-07-25       Impact factor: 5.157

2.  Use of affinity capillary electrophoresis to determine kinetic and equilibrium constants for binding of arylsulfonamides to bovine carbonic anhydrase.

Authors:  L Z Avila; Y H Chu; E C Blossey; G M Whitesides
Journal:  J Med Chem       Date:  1993-01-08       Impact factor: 7.446

Review 3.  Genetics and mechanisms of glycopeptide resistance in enterococci.

Authors:  M Arthur; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

4.  Drug resistance plasmids in Lactobacillus acidophilus and Lactobacillus reuteri.

Authors:  M Vescovo; L Morelli; V Bottazzi
Journal:  Appl Environ Microbiol       Date:  1982-01       Impact factor: 4.792

5.  Structure of vancomycin and its complex with acetyl-D-alanyl-D-alanine.

Authors:  G M Sheldrick; P G Jones; O Kennard; D H Williams; G A Smith
Journal:  Nature       Date:  1978-01-19       Impact factor: 49.962

6.  Modified peptidoglycan precursors produced by glycopeptide-resistant enterococci.

Authors:  J Messer; P E Reynolds
Journal:  FEMS Microbiol Lett       Date:  1992-07-01       Impact factor: 2.742

7.  Biosynthesis of modified peptidoglycan precursors by vancomycin-resistant Enterococcus faecium.

Authors:  N E Allen; J N Hobbs; J M Richardson; R M Riggin
Journal:  FEMS Microbiol Lett       Date:  1992-11-01       Impact factor: 2.742

8.  Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147.

Authors:  M Arthur; C Molinas; F Depardieu; P Courvalin
Journal:  J Bacteriol       Date:  1993-01       Impact factor: 3.490

9.  Effects of amino acids on expression of enterococcal vancomycin resistance.

Authors:  L J Zarlenga; M S Gilmore; D F Sahm
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

10.  Modifications of the acyl-D-alanyl-D-alanine terminus affecting complex-formation with vancomycin.

Authors:  M Nieto; H R Perkins
Journal:  Biochem J       Date:  1971-08       Impact factor: 3.857

View more
  29 in total

Review 1.  Vancomycin-resistant enterococci.

Authors:  Y Cetinkaya; P Falk; C G Mayhall
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  Peptidoglycan structure of Lactobacillus casei, a species highly resistant to glycopeptide antibiotics.

Authors:  D Billot-Klein; R Legrand; B Schoot; J van Heijenoort; L Gutmann
Journal:  J Bacteriol       Date:  1997-10       Impact factor: 3.490

3.  Determination of the anomeric configuration of glycosyl esters of nucleoside pyrophosphates and polyisoprenyl phosphates by fast-atom bombardment tandem mass spectrometry.

Authors:  B A Wolucka; E de Hoffmann; J S Rush; C J Waechter
Journal:  J Am Soc Mass Spectrom       Date:  1996-06       Impact factor: 3.109

Review 4.  Current perspectives on glycopeptide resistance.

Authors:  N Woodford; A P Johnson; D Morrison; D C Speller
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

Review 5.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

6.  A thioredoxin fusion protein of VanH, a D-lactate dehydrogenase from Enterococcus faecium: cloning, expression, purification, kinetic analysis, and crystallization.

Authors:  V S Stoll; A V Manohar; W Gillon; E L MacFarlane; R C Hynes; E F Pai
Journal:  Protein Sci       Date:  1998-05       Impact factor: 6.725

7.  Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.

Authors:  E Kheadr; N Dabour; C Le Lay; C Lacroix; I Fliss
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

8.  Determination of the anomeric configuration of glycosyl esters of nucleoside pyrophosphates by fast-atom bombardment tandem mass spectrometry.

Authors:  B A Wolucka; E de Hoffmann
Journal:  J Am Soc Mass Spectrom       Date:  1995-06       Impact factor: 3.109

9.  Lactobacillus species identification, H2O2 production, and antibiotic resistance and correlation with human clinical status.

Authors:  A Felten; C Barreau; C Bizet; P H Lagrange; A Philippon
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

10.  DdlN from vancomycin-producing Amycolatopsis orientalis C329.2 is a VanA homologue with D-alanyl-D-lactate ligase activity.

Authors:  C G Marshall; G D Wright
Journal:  J Bacteriol       Date:  1998-11       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.